Investors / United Kingdom / Embryo Ventures
Embryo Ventures
Venture capital · London, United Kingdom · Europe
Embryo Ventures is an early-stage venture capital firm that backs founders across human health and human experience. It invests across pre-seed to Series A, from pre-product and pre-revenue stages, and is active in the UK, Europe and the US while considering opportunistic investments globally.
Invests inHealthcare & Biotech
In its own wordshealthwellnessbiosensingbrain-machine interfacesconsumer healthhuman experience
Your fit with Embryo Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsEmbryo Ventures lists 12 checked portfolio companies on its own site and is named in 1 funding round. Its most frequent entry is Seed, 100% of the companies with a known first round. Its largest themes are Healthcare & Biotech (44%), Food & Agriculture (11%) and Climate & Energy (6%). 67% of its companies are based in United Kingdom. It invests most often alongside The Conduit Connect, 1818 Venture Capital and Antler.
Counts come from funding rounds that name Embryo Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Embryo Ventures' whole history. Rounds on record name 1 company; its own site lists 12. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 100% |
| Series A | 0% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 1 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 30th | 12 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 100th | 100% of entries at pre-seed or seed |
| Evidence | 73th | 8% of companies confirmed by a round |
| Sector focus | 79th | 44% in its largest sector |
| Reach | 70th | 4 countries |
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 44% | 15% |
| Food & Agriculture | 11% | 3% |
| Climate & Energy | 6% | 1% |
| Industrial & Manufacturing | 6% | 7% |
| Fintech | 6% | 12% |
| E-commerce & Marketplaces | 6% | 6% |
| Mobility & Logistics | 6% | 1% |
| AI & Machine Learning | 6% | 18% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| The Conduit Connect | 2 |
| 1818 Venture Capital | 1 |
| Antler | 1 |
| Avalancha Ventures | 1 |
| Boost VC | 1 |
| Cornerstone VC | 1 |
| Creative Destruction Lab | 1 |
| DART Ventures | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers12100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with The Conduit Connect
Compare Embryo Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Embryo Ventures| Date | Company | Stage |
|---|---|---|
| 16 Oct 2026 | Seed |
Round details for Embryo Ventures
Amounts, full round histories and every co-investor in Embryo Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
12 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Biolumen develops an all-natural structured fiber that absorbs sugars and fats to reduce calorie intake and promote a healthy gut. | Healthcare & BiotechFood & Agriculture | Portfolio page | ||
| Bridgefy is a free messaging app that works without the Internet. | ConsumerEnterprise Software | Portfolio page | ||
| Calla Lily Clinical Care develops vaginal drug delivery technology | Healthcare & Biotech | Portfolio page | ||
| Gladys is a home care agency that connects you directly with experienced and vetted carers and helpers to offer support at home. | Healthcare & Biotech | Portfolio page | ||
| Impli develops implantable technology to monitor and understand biological data with medical-grade precision | Healthcare & Biotech | Portfolio page | ||
| Laka provides bicycle insurance to cyclists | FintechHealthcare & Biotech | Portfolio page | ||
| OSSTEC develops and provides biomimetic cementless fixation technology for joint replacement surgery | Healthcare & Biotech | Portfolio page | ||
| Pluvo develops and delivers clean air technologies that tackle air pollution | Healthcare & BiotechClimate & Energy | Portfolio page | ||
| STAXY helps organisations cut costs and emissions by delivering low-cost, convenient travel through AI powered data collection and mobility-as-a-service technology. | Mobility & LogisticsAI & Machine Learning | Portfolio page | ||
| TasteIndex enables customers to select unknown products based on their personal taste preference | Food & AgricultureE-commerce & Marketplaces | Portfolio page | ||
| Thermulon produces aerogels using a proprietary process | Industrial & Manufacturing | Portfolio page | ||
| Unravel Health develops a device that measures multiple hormones in saliva, providing near real-time results and revealing patterns that blood tests may miss. | Healthcare & Biotech | Oct 2026Seed | Page + round |
About this data
site last read 5 Nov 2026- Site
- embryoventures.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 16 Oct 2026
- Companies checked
- 12
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Embryo Ventures' profile as data
Pull Embryo Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/embryoventures.com
# also
GET /v1/firms/embryoventures.com/portfolio
GET /v1/firms/embryoventures.com/coinvestors
GET /v1/firms/embryoventures.com/news